Latest Virus-like particle Stories

2014-06-10 12:32:11

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Novavax, Inc. - Product Pipeline Review - 2014http://www.reportbuyer.com/pharma_healthcare/therapeutic/novavax_inc_product_pipeline_review_2013.html Novavax, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Direct's, 'Novavax, Inc. - Product Pipeline Review - 2014', provides an overview of the Novavax, Inc.'s pharmaceutical research and development focus.This report provides...

2014-03-25 08:30:28

ROCKVILLE, Md., March 25, 2014 /PRNewswire/ -- VLP Therapeutics, Inc. ("VLP"), a Rockville-based biotechnology company focusing on the research and development of next generation antibody agents and therapeutic as well as preventive vaccines based upon a novel and proprietary i- VLP technology (which stands for "inserted alpha virus like particle"), today announced that Ryuji Ueno, M.D., Ph.D., Ph.D., Co-Founder and former Chair, Chief Executive Officer and Chief Scientific Officer of...

2014-03-07 12:25:48

Instrumentation Allows for High Resolution Mass and Size Analysis of Proteins, Antibody Aggregates, Viruses/Vaccines/VLPs, Polymers, and Nanoparticles SHOREVIEW, Minn., March 7, 2014 /PRNewswire/ -- TSI, a worldwide leader in precision measurement instrumentation, announces the launch of its new MacroIMS(TM) Macroion Spectrometer. The MacroIMS Macroion Mobility Spectrometer 3982 is a powerful new tool for rapid, high-resolution molecular size and mass analysis of macromolecules....

2014-01-29 00:20:55

SINGAPORE and ZURICH, January 29, 2014 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that their influenza vaccine (gH1-Qbeta) met its primary end point for immunogenicity (seroconversion based on haemaglutination inhibition titres according to FDA criteria) in the Phase 1 clinical trial in healthy Asian volunteers. The induced immune response showed good cross-reactivity to recent...

2014-01-23 23:05:00

GIA announces the release of a trend report on Virus-Like Particles (VLPs). Market for Virus-Like Particles (VLPs) is projected to witness growth led by technological advancements in vaccine development. San Jose, California (PRWEB) January 23, 2014 Virus-like particles (VLPs) bear high structural resemblance to viruses, though completely non-infectious in nature due to the absence of viral genetic material. Despite lacking DNA material, VLPs retain key immunological characteristics of...

Word of the Day
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).